Experts and Doctors on pyridines in Melbourne, Victoria, Australia
Locale: Melbourne, Victoria, Australia
Zhang X, Lassila M, Cooper M, Cao Z. Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors. Hypertension. 2004;43:276-81 pubmed
..These findings suggest that VEGF expression is modulated by AT1 and AT2 receptors, thereby implicating angiotensin II receptor subtypes in retinal diseases such as diabetic retinopathy. ..
Rizkalla B, Forbes J, Cao Z, Boner G, Cooper M. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J Hypertens. 2005;23:153-64 pubmed
..Furthermore, the effects of angiotensin II receptor blockade on these parameters is consistent with the VEGF-VEGF-R2 and angiopoietin-Tie-2 axes being modulated in the kidney by haemodynamic factors in the diabetic context. ..
Kelleher F, Cain J, Healy J, Watkins D, Thomas D. Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacol Ther. 2012;136:153-68 pubmed publisher
..In this context secondary resistance of medulloblastomas to treatment with a smoothened antagonist in two tumor mouse models is examined. ..
Cameron L, Jiang D, Moodie K, Mitchell C, Solomon B, Parameswaran B. Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution. Cancer Imaging. 2017;17:7 pubmed publisher
..This unusual manifestation of chemotherapy should be recognised, particularly by radiologists, so that inappropriate treatment decisions are avoided. ..
He H, Yim M, Liu K, Cody S, Shulkes A, Baldwin G. Involvement of G proteins of the Rho family in the regulation of Bcl-2-like protein expression and caspase 3 activation by Gastrins. Cell Signal. 2008;20:83-93 pubmed
..The findings offer potential targets for blocking the growth-stimulating effects of these gastrins. ..
Chu P, Zatta A, Kiriazis H, Chin Dusting J, Du X, Marshall T, et al
. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circ Heart Fail. 2011;4:651-8 pubmed publisher
..This insight provides a new potential therapeutic approach for the treatment of specific aspects of mineralocorticoid mediated cardiovascular disease. ..